local_hospital

MUDr. David Zeman s.r.o.

Address
lock Available on a paid plan

Bacterial Infections and Mycoses

At MUDr. David Zeman s.r.o. in Poruba, research in this area focuses on meningococcal infection and related vaccine studies. The trials are designed to assess immune response and safety, helping determine whether a new meningococcal ACYW conjugate vaccine performs as well as an established comparator in young children.

  • Study of meningococcal disease prevention in healthy infants and toddlers
  • Evaluation of antibody response to key meningococcal serogroups A, C, W, and Y
  • Assessment of vaccine effectiveness and overall safety in early childhood

This research supports better protection against serious bacterial infection through improved vaccination strategies for pediatric populations.

Virus Diseases

The site is also involved in clinical trials for varicella, with a strong emphasis on chickenpox vaccine research. These studies aim to confirm immune consistency across vaccine batches and compare a candidate varicella zoster virus vaccine with an existing vaccine, while also monitoring safety in healthy children.

  • Investigation of chickenpox prevention in healthy children aged 12 to 15 months
  • Measurement of immune response to varicella zoster virus after vaccination
  • Comparison of a new varicella vaccine with a standard option to support reliable protection

These trials help advance viral infection prevention by testing whether the investigational vaccine can deliver consistent and effective protection for young children.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
2areas
Outperforms 63% of sites
groups
Sponsor diversity
2sponsors
Outperforms 50% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in MUDr. David Zeman s.r.o.

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Phase 3a Randomized Study on Lot Consistency, Immunogenicity, and Safety of GSKVX000000025896 vs. Varicella Virus Oka/Merck Strain in Healthy ChildrenGlaxoSmithKline BiologicalsPhase IIIRecruitingJul 2025

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
GSKVX0000000258961Unknown2025-07-082025-07-08

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.